Kronos Bio, Inc. (KRON)
NASDAQ: KRON · IEX Real-Time Price · USD
1.260
+0.010 (0.80%)
Jul 22, 2024, 10:59 AM EDT - Market open
Kronos Bio Employees
As of December 31, 2023, Kronos Bio had 63 total employees, including 62 full-time and 1 part-time employees. The number of employees decreased by 34 or -35.05% compared to the previous year.
Employees
63
Change (1Y)
-34
Growth (1Y)
-35.05%
Revenue / Employee
$120,429
Profits / Employee
-$1,847,508
Market Cap
75.71M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 63 | -34 | -35.05% |
Dec 31, 2022 | 97 | 1 | 1.04% |
Dec 31, 2021 | 96 | 33 | 52.38% |
Dec 31, 2020 | 63 | - | - |
Related Stocks
Company Name | Employees |
---|---|
MDxHealth | 300 |
Eagle Pharmaceuticals | 134 |
Theratechnologies | 103 |
Spero Therapeutics | 46 |
Ovid Therapeutics | 40 |
enVVeno Medical | 31 |
Cognition Therapeutics | 28 |
Genelux | 23 |
KRON News
- 2 months ago - Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewsWire
- 2 months ago - Kronos Bio to Participate in Three Upcoming Healthcare Conferences and Events - GlobeNewsWire
- 2 months ago - Kronos Bio Appoints Deborah Knobelman, Ph.D. as Chief Operating Officer and Chief Financial Officer - GlobeNewsWire
- 2 months ago - Kronos Bio Reports First-Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2023 Financial Results - GlobeNewsWire
- 4 months ago - How Does Kronos Stock Look After Its 15% Rise Last Week? - Forbes
- 4 months ago - Kronos Bio Announces Restructuring to Focus Resources on Clinical Development with Extended Cash Runway - GlobeNewsWire
- 4 months ago - Kronos Bio To Present Three Posters at AACR 2024 Annual Meeting - GlobeNewsWire